ChemWerth Appoints New General Sales Manager To Increase Its Generic API Footprint in India
News > Business News
Audio By Carbonatix
9:30 PM on Sunday, January 11
The Associated Press
WOODBRIDGE, Conn.--(BUSINESS WIRE)--Jan 12, 2026--
ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market. To support its growth in the region, ChemWerth has hired Chandrakanth Reddy as general sales manager of its India office.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260111302280/en/
Chandrakanth Reddy has joined ChemWerth, Inc., as general sales manager of its India office.
“The addition of a general sales manager in India signals our desire to grow our presence and customer base in the world’s most important generic pharmaceutical market,” said Pete Werth III, president, ChemWerth. “Chandrakanth will add tremendous value for our customers and contract manufacturing organizations (CMOs) in India.”
Reddy is a seasoned pharmaceutical professional with more than 16 years of experience spanning API sourcing, business development, market expansion and regulatory-driven commercial strategy. He has successfully led high-value markets across India, the Middle East, North Africa, Europe, and the United States, building strong customer partnerships and supporting sustainable revenue growth.
In his new role, Reddy will be responsible for leading ChemWerth’s sales strategy in India and strengthening regional customer relationships. He will also support the company’s focused initiative to roll out new generic APIs in the market, including fermentation, peptide and oncology injectable APIs.
“After reviewing ChemWerth’s strategic plan to unveil a strong pipeline of new generic fermentation, peptide and oncology injectable APIs for the Indian market, I knew that was something I wanted to be a part of,” said Reddy.
About ChemWerth, Inc.:
Established in 1982, ChemWerth is a full-service generic active pharmaceutical ingredient (API) development and supply company providing cGMP-quality APIs to regulated markets worldwide. ChemWerth is a global company headquartered in the United States, with offices in China and India. For more information, please visit www.chemwerth.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20260111302280/en/
CONTACT: Patrick Lajoie
KEYWORD: CONNECTICUT UNITED STATES INDIA NORTH AMERICA ASIA PACIFIC
INDUSTRY KEYWORD: MANUFACTURING HEALTH PHARMACEUTICAL CHEMICALS/PLASTICS MEDICAL SUPPLIES
SOURCE: ChemWerth, Inc.
Copyright Business Wire 2026.
PUB: 01/12/2026 12:30 AM/DISC: 01/12/2026 12:30 AM
http://www.businesswire.com/news/home/20260111302280/en